vs
Side-by-side financial comparison of COMSCORE, INC. (SCOR) and VIEMED HEALTHCARE, INC. (VMD). Click either name above to swap in a different company.
COMSCORE, INC. is the larger business by last-quarter revenue ($93.5M vs $76.2M, roughly 1.2× VIEMED HEALTHCARE, INC.). VIEMED HEALTHCARE, INC. runs the higher net margin — 7.4% vs 3.2%, a 4.2% gap on every dollar of revenue. On growth, VIEMED HEALTHCARE, INC. posted the faster year-over-year revenue change (25.5% vs -1.5%). VIEMED HEALTHCARE, INC. produced more free cash flow last quarter ($9.7M vs $2.9M). Over the past eight quarters, VIEMED HEALTHCARE, INC.'s revenue compounded faster (22.7% CAGR vs 3.8%).
Comscore, Inc. is an American-based global media measurement and analytics company providing marketing data and analytics to enterprises, advertising agencies, brand marketers, and publishers.
Viemed Healthcare, Inc. is a medical technology firm specializing in respiratory care solutions. It develops, manufactures and distributes portable ventilators, respiratory therapy devices and related support services, catering to acute care, post-acute care and home care segments across North America, Europe and key Asia-Pacific markets for patients with respiratory conditions.
SCOR vs VMD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $93.5M | $76.2M |
| Net Profit | $3.0M | $5.6M |
| Gross Margin | 41.0% | 57.9% |
| Operating Margin | 7.0% | 11.0% |
| Net Margin | 3.2% | 7.4% |
| Revenue YoY | -1.5% | 25.5% |
| Net Profit YoY | -3.7% | 30.7% |
| EPS (diluted) | $9.50 | $0.14 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $93.5M | $76.2M | ||
| Q3 25 | $88.9M | $71.9M | ||
| Q2 25 | $89.4M | $63.1M | ||
| Q1 25 | $85.7M | $59.1M | ||
| Q4 24 | $94.9M | $60.7M | ||
| Q3 24 | $88.5M | $58.0M | ||
| Q2 24 | $85.8M | $55.0M | ||
| Q1 24 | $86.8M | $50.6M |
| Q4 25 | $3.0M | $5.6M | ||
| Q3 25 | $453.0K | $3.5M | ||
| Q2 25 | $-9.5M | $3.2M | ||
| Q1 25 | $-4.0M | $2.6M | ||
| Q4 24 | $3.1M | $4.3M | ||
| Q3 24 | $-60.6M | $3.9M | ||
| Q2 24 | $-1.7M | $1.5M | ||
| Q1 24 | $-1.1M | $1.6M |
| Q4 25 | 41.0% | 57.9% | ||
| Q3 25 | 40.6% | 57.5% | ||
| Q2 25 | 40.6% | 58.3% | ||
| Q1 25 | 39.6% | 56.3% | ||
| Q4 24 | 42.4% | 59.5% | ||
| Q3 24 | 41.2% | 59.3% | ||
| Q2 24 | 39.5% | 59.8% | ||
| Q1 24 | 42.3% | 58.9% |
| Q4 25 | 7.0% | 11.0% | ||
| Q3 25 | 1.9% | 7.8% | ||
| Q2 25 | -1.9% | 8.1% | ||
| Q1 25 | -2.4% | 6.5% | ||
| Q4 24 | 4.1% | 10.6% | ||
| Q3 24 | -67.4% | 9.7% | ||
| Q2 24 | -2.2% | 6.6% | ||
| Q1 24 | -2.2% | 4.4% |
| Q4 25 | 3.2% | 7.4% | ||
| Q3 25 | 0.5% | 4.9% | ||
| Q2 25 | -10.6% | 5.0% | ||
| Q1 25 | -4.7% | 4.4% | ||
| Q4 24 | 3.3% | 7.1% | ||
| Q3 24 | -68.5% | 6.7% | ||
| Q2 24 | -2.0% | 2.7% | ||
| Q1 24 | -1.2% | 3.2% |
| Q4 25 | $9.50 | $0.14 | ||
| Q3 25 | $-0.86 | $0.09 | ||
| Q2 25 | $-2.73 | $0.08 | ||
| Q1 25 | $-1.66 | $0.06 | ||
| Q4 24 | $-0.47 | $0.10 | ||
| Q3 24 | $-12.79 | $0.10 | ||
| Q2 24 | $-1.19 | $0.04 | ||
| Q1 24 | $-1.08 | $0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $23.6M | $13.5M |
| Total DebtLower is stronger | $41.5M | — |
| Stockholders' EquityBook value | $111.4M | $141.5M |
| Total Assets | $407.7M | $199.2M |
| Debt / EquityLower = less leverage | 0.37× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $23.6M | $13.5M | ||
| Q3 25 | $26.7M | $11.1M | ||
| Q2 25 | $26.0M | $20.0M | ||
| Q1 25 | $31.0M | $10.2M | ||
| Q4 24 | $29.9M | $17.5M | ||
| Q3 24 | $20.0M | $11.3M | ||
| Q2 24 | $14.7M | $8.8M | ||
| Q1 24 | $18.7M | $7.3M |
| Q4 25 | $41.5M | — | ||
| Q3 25 | $41.4M | — | ||
| Q2 25 | $41.3M | — | ||
| Q1 25 | $41.3M | — | ||
| Q4 24 | $41.2M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $111.4M | $141.5M | ||
| Q3 25 | $-26.3M | $133.6M | ||
| Q2 25 | $-21.7M | $139.7M | ||
| Q1 25 | $-13.5M | $134.8M | ||
| Q4 24 | $-8.3M | $131.4M | ||
| Q3 24 | $-2.7M | $125.0M | ||
| Q2 24 | $45.8M | $119.4M | ||
| Q1 24 | $51.4M | $116.3M |
| Q4 25 | $407.7M | $199.2M | ||
| Q3 25 | $406.9M | $202.4M | ||
| Q2 25 | $415.9M | $184.6M | ||
| Q1 25 | $421.5M | $178.1M | ||
| Q4 24 | $430.2M | $177.1M | ||
| Q3 24 | $412.5M | $169.5M | ||
| Q2 24 | $474.1M | $163.9M | ||
| Q1 24 | $477.7M | $154.9M |
| Q4 25 | 0.37× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $3.2M | $18.4M |
| Free Cash FlowOCF − Capex | $2.9M | $9.7M |
| FCF MarginFCF / Revenue | 3.1% | 12.7% |
| Capex IntensityCapex / Revenue | 0.3% | 11.5% |
| Cash ConversionOCF / Net Profit | 1.07× | 3.27× |
| TTM Free Cash FlowTrailing 4 quarters | $21.8M | $11.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.2M | $18.4M | ||
| Q3 25 | $9.5M | $18.4M | ||
| Q2 25 | $932.0K | $12.3M | ||
| Q1 25 | $9.1M | $2.9M | ||
| Q4 24 | $-10.0M | $15.0M | ||
| Q3 24 | $12.5M | $12.7M | ||
| Q2 24 | $8.7M | $10.2M | ||
| Q1 24 | $6.9M | $1.2M |
| Q4 25 | $2.9M | $9.7M | ||
| Q3 25 | $9.4M | $10.7M | ||
| Q2 25 | $787.0K | $4.1M | ||
| Q1 25 | $8.7M | $-12.6M | ||
| Q4 24 | $-10.3M | $3.2M | ||
| Q3 24 | $12.4M | $1.7M | ||
| Q2 24 | $8.5M | $1.2M | ||
| Q1 24 | $6.6M | $-4.8M |
| Q4 25 | 3.1% | 12.7% | ||
| Q3 25 | 10.5% | 14.9% | ||
| Q2 25 | 0.9% | 6.5% | ||
| Q1 25 | 10.1% | -21.4% | ||
| Q4 24 | -10.8% | 5.2% | ||
| Q3 24 | 14.0% | 3.0% | ||
| Q2 24 | 10.0% | 2.3% | ||
| Q1 24 | 7.6% | -9.5% |
| Q4 25 | 0.3% | 11.5% | ||
| Q3 25 | 0.1% | 10.6% | ||
| Q2 25 | 0.2% | 12.9% | ||
| Q1 25 | 0.4% | 26.2% | ||
| Q4 24 | 0.2% | 19.5% | ||
| Q3 24 | 0.1% | 19.0% | ||
| Q2 24 | 0.2% | 16.3% | ||
| Q1 24 | 0.3% | 11.9% |
| Q4 25 | 1.07× | 3.27× | ||
| Q3 25 | 20.96× | 5.23× | ||
| Q2 25 | — | 3.88× | ||
| Q1 25 | — | 1.09× | ||
| Q4 24 | -3.19× | 3.47× | ||
| Q3 24 | — | 3.29× | ||
| Q2 24 | — | 6.94× | ||
| Q1 24 | — | 0.73× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SCOR
| Transferred Over Time | $77.1M | 83% |
| Research Insight Solutions | $14.6M | 16% |
| Related Party | $2.5M | 3% |
VMD
Segment breakdown not available.
